CUAMC
China Universal Asset Management Company’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $541K | Buy |
18,815
+151
| +0.8% | +$4.34K | 0.05% | 234 |
|
|
2025
Q1 | $626K | Sell |
18,664
-1,000
| -5% | -$33.5K | 0.06% | 225 |
|
|
2024
Q4 | $1.01M | Buy |
19,664
+4,271
| +28% | +$218K | 0.09% | 161 |
|
|
2024
Q3 | $787K | Buy |
15,393
+6,128
| +66% | +$313K | 0.09% | 162 |
|
|
2024
Q2 | $415K | Sell |
9,265
-4,099
| -31% | -$184K | 0.06% | 162 |
|
|
2024
Q1 | $626K | Buy |
13,364
+5,643
| +73% | +$264K | 0.08% | 166 |
|
|
2023
Q4 | $275K | Buy |
7,721
+6,318
| +450% | +$225K | 0.05% | 180 |
|
|
2023
Q3 | $41.7K | Buy |
1,403
+695
| +98% | +$20.7K | 0.01% | 240 |
|
|
2023
Q2 | $12.8K | Sell |
708
-23
| -3% | -$414 | ﹤0.01% | 304 |
|
|
2023
Q1 | $11.7K | Buy |
731
+184
| +34% | +$2.96K | ﹤0.01% | 271 |
|
|
2022
Q4 | $10K | Buy |
547
+44
| +9% | +$805 | ﹤0.01% | 226 |
|
|
2022
Q3 | $10K | Buy |
+503
| New | +$10K | ﹤0.01% | 204 |
|